SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micromet Inc (MITI) -- Ignore unavailable to you. Want to Upgrade?


To: Saulamanca who wrote (54)1/12/2009 11:48:00 AM
From: Steve Lokness  Read Replies (1) | Respond to of 196
 
Under the terms of the agreement, Bayer Schering Pharma will pay Micromet a Euro 4.5 million fee (approx. US$ 6 million) to secure a one year option on a specific BiTE antibody.

An option. So how did this come about do you suppose?

steve